Publications by authors named "Edelyne Tandanu"

Introduction: The new preference-informed allocation (PIA) system introduced for the 2024 UK cohort Foundation Programme (UKFPO) marks a shift away from the traditional meritocratic 'ranking' used in previous years. Instead of appointment to Foundation Programme places, PIA is a computer-generated allocation and deanery preferencing system. This change has raised numerous concerns among both students and clinicians.

View Article and Find Full Text PDF

Objective: The objective of this study was to determine the incidence of venous thromboembolism (VTE) following autologous breast reconstruction, assess risk factors that may predict incidence and assess the accuracy of the Caprini risk assessment model.

Background: VTE is a rare, but potentially lethal complication of autologous breast reconstruction. An accurate preoperative risk-stratification strategy is essential to improve patient outcomes by determining the patients who would benefit from extended thromboprophylaxis after surgery.

View Article and Find Full Text PDF
Article Synopsis
  • A mentorship scheme was established to enhance medical students' exposure to surgery by pairing them with local surgeons, aiming to improve their understanding and insight into surgical careers.
  • Evaluation of the program, which involved 35 surgeons and 37 students, showed significant increases in students' confidence and hands-on experience in surgery, with 81% focusing on research and 67% seeking theatre experience.
  • Results indicated that 95% of participants would recommend the scheme, highlighting its effectiveness in supporting students in pursuing surgical careers and supplementing their medical education.
View Article and Find Full Text PDF

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited cardiac ion channelopathy where the initial disease presentation is during childhood or adolescent stages, leading to increased risks of sudden cardiac death. Despite advances in medical science and technology, several gaps remain in the understanding of the molecular mechanisms, risk prediction, and therapeutic management of patients with CPVT. Recent studies have identified and validated seven sets of genes responsible for various CPVT phenotypes, including RyR2, CASQ-2, TRDN, CALM1, 2, and 3, and TECRL, providing novel insights into the molecular mechanisms.

View Article and Find Full Text PDF